Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Studying Brain Function in Children Using Magnetoencephalography.

Rapaport H, Seymour RA, Sowman PF, Benikos N, Stylianou E, Johnson BW, Crain S, He W.

J Vis Exp. 2019 Apr 8;(146). doi: 10.3791/58909.

PMID:
31009000
2.

Author Correction: The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.

Tanner R, O'Shea MK, White AD, Müller J, Harrington-Kandt R, Matsumiya M, Dennis MJ, Parizotto EA, Harris S, Stylianou E, Naranbhai V, Bettencourt P, Drakesmith H, Sharpe S, Fletcher HA, McShane H.

Sci Rep. 2019 Apr 3;9(1):5596. doi: 10.1038/s41598-019-41387-8.

3.

Correction: Work-related hand eczema.

Kvam MS, Alfonso JH, Berents TL, Randem BG, Stylianou E.

Tidsskr Nor Laegeforen. 2019 Feb 8;139(4). doi: 10.4045/tidsskr.19.0125. Print 2019 Feb 26. Norwegian. No abstract available.

4.

Work-related hand eczema.

Kvam MS, Alfonso JH, Berents TL, Randem BG, Stylianou E.

Tidsskr Nor Laegeforen. 2019 Feb 5;139(3). doi: 10.4045/tidsskr.18.0213. Print 2019 Feb 12. English, Norwegian. No abstract available. Erratum in: Tidsskr Nor Laegeforen. 2019 Feb 08;139(4):.

5.

Data on knowledge and beliefs of students, physicians and other health professionals about ethical issues in Cyprus.

Christou R, Michael N, Stylianou E, Yiallourou AI, Pantavou K, Nikolopoulos GK.

Data Brief. 2019 Jan 22;22:1031-1035. doi: 10.1016/j.dib.2019.01.046. eCollection 2019 Feb.

6.

Epigenetics of chronic inflammatory diseases.

Stylianou E.

J Inflamm Res. 2018 Dec 20;12:1-14. doi: 10.2147/JIR.S129027. eCollection 2019. Review.

7.

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin.

McNeill E, Stylianou E, Crabtree MJ, Harrington-Kandt R, Kolb AL, Diotallevi M, Hale AB, Bettencourt P, Tanner R, O'Shea MK, Matsumiya M, Lockstone H, Müller J, Fletcher HA, Greaves DR, McShane H, Channon KM.

Nat Commun. 2018 Dec 20;9(1):5409. doi: 10.1038/s41467-018-07714-9.

8.

Improvement on bioprocess economics for 2,3-butanediol production from very high polarity cane sugar via optimisation of bioreactor operation.

Maina S, Stylianou E, Vogiatzi E, Vlysidis A, Mallouchos A, Nychas GE, de Castro AM, Dheskali E, Kookos IK, Koutinas A.

Bioresour Technol. 2019 Feb;274:343-352. doi: 10.1016/j.biortech.2018.11.001. Epub 2018 Nov 2.

PMID:
30529482
9.

Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1- CD4+ T cells.

Bull NC, Stylianou E, Kaveh DA, Pinpathomrat N, Pasricha J, Harrington-Kandt R, Garcia-Pelayo MC, Hogarth PJ, McShane H.

Mucosal Immunol. 2019 Mar;12(2):555-564. doi: 10.1038/s41385-018-0109-1. Epub 2018 Nov 16.

PMID:
30446726
10.

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection.

O'Shea MK, Tanner R, Müller J, Harris SA, Wright D, Stockdale L, Stylianou E, Satti I, Smith SG, Dunbar J, Fletcher TE, Dedicoat M, Cunningham AF, McShane H.

Sci Rep. 2018 Sep 27;8(1):14480. doi: 10.1038/s41598-018-32755-x.

11.

Hypersensitivity reactions with prolonged infusions of β-lactams?

Fjeld H, Stylianou E.

Clin Microbiol Infect. 2019 Jan;25(1):121-122. doi: 10.1016/j.cmi.2018.08.021. Epub 2018 Sep 7. No abstract available.

PMID:
30195470
12.

Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4+ T cell population following BCG immunisation.

Bull NC, Kaveh DA, Garcia-Pelayo MC, Stylianou E, McShane H, Hogarth PJ.

Vaccine. 2018 Sep 5;36(37):5625-5635. doi: 10.1016/j.vaccine.2018.07.035. Epub 2018 Aug 7.

13.

Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate Tuberculosis Subunit Vaccine.

Stylianou E, Harrington-Kandt R, Beglov J, Bull N, Pinpathomrat N, Swarbrick GM, Lewinsohn DA, Lewinsohn DM, McShane H.

Infect Immun. 2018 Jun 21;86(7). pii: e00014-18. doi: 10.1128/IAI.00014-18. Print 2018 Jul.

14.

Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model.

Harrington-Kandt R, Stylianou E, Eddowes LA, Lim PJ, Stockdale L, Pinpathomrat N, Bull N, Pasricha J, Ulaszewska M, Beglov Y, Vaulont S, Drakesmith H, McShane H.

PLoS One. 2018 Jan 11;13(1):e0191038. doi: 10.1371/journal.pone.0191038. eCollection 2018.

15.

Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.

Stylianou E.

Mol Diagn Ther. 2018 Feb;22(1):11-23. doi: 10.1007/s40291-017-0298-4. Review.

PMID:
28900867
16.

The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.

Brennan MJ, Tanner R, Morris S, Scriba TJ, Achkar JM, Zelmer A, Hokey DA, Izzo A, Sharpe S, Williams A, Penn-Nicholson A, Erasmus M, Stylianou E, Hoft DF, McShane H, Fletcher HA.

Clin Vaccine Immunol. 2017 Sep 5;24(9). pii: e00142-17. doi: 10.1128/CVI.00142-17. Print 2017 Sep. Review.

17.

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.

Tanner R, O'Shea MK, White AD, Müller J, Harrington-Kandt R, Matsumiya M, Dennis MJ, Parizotto EA, Harris S, Stylianou E, Naranbhai V, Bettencourt P, Drakesmith H, Sharpe S, Fletcher HA, McShane H.

Sci Rep. 2017 Mar 3;7:43478. doi: 10.1038/srep43478. Erratum in: Sci Rep. 2019 Apr 3;9(1):5596.

18.

Enhancing the Biological Relevance of Machine Learning Classifiers for Reverse Vaccinology.

Heinson AI, Gunawardana Y, Moesker B, Hume CC, Vataga E, Hall Y, Stylianou E, McShane H, Williams A, Niranjan M, Woelk CH.

Int J Mol Sci. 2017 Feb 1;18(2). pii: E312. doi: 10.3390/ijms18020312.

19.

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.

Zelmer A, Tanner R, Stylianou E, Damelang T, Morris S, Izzo A, Williams A, Sharpe S, Pepponi I, Walker B, Hokey DA, McShane H, Brennan M, Fletcher H.

BMC Infect Dis. 2016 Aug 12;16:412. doi: 10.1186/s12879-016-1751-4.

20.

Genome-wide analysis identifies differential promoter methylation of Leprel2, Foxf1, Mmp25, Igfbp6, and Peg12 in murine tendinopathy.

Trella KJ, Li J, Stylianou E, Wang VM, Frank JM, Galante J, Sandy JD, Plaas A, Wysocki R.

J Orthop Res. 2017 May;35(5):947-955. doi: 10.1002/jor.23393. Epub 2016 Aug 29.

21.

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.

Fletcher HA, Snowden MA, Landry B, Rida W, Satti I, Harris SA, Matsumiya M, Tanner R, O'Shea MK, Dheenadhayalan V, Bogardus L, Stockdale L, Marsay L, Chomka A, Harrington-Kandt R, Manjaly-Thomas ZR, Naranbhai V, Stylianou E, Darboe F, Penn-Nicholson A, Nemes E, Hatherill M, Hussey G, Mahomed H, Tameris M, McClain JB, Evans TG, Hanekom WA, Scriba TJ, McShane H.

Nat Commun. 2016 May 6;7:11633. doi: 10.1038/ncomms11633. No abstract available.

22.

T-cell activation is an immune correlate of risk in BCG vaccinated infants.

Fletcher HA, Snowden MA, Landry B, Rida W, Satti I, Harris SA, Matsumiya M, Tanner R, O'Shea MK, Dheenadhayalan V, Bogardus L, Stockdale L, Marsay L, Chomka A, Harrington-Kandt R, Manjaly-Thomas ZR, Naranbhai V, Stylianou E, Darboe F, Penn-Nicholson A, Nemes E, Hatherill M, Hussey G, Mahomed H, Tameris M, McClain JB, Evans TG, Hanekom WA, Scriba TJ, McShane H.

Nat Commun. 2016 Apr 12;7:11290. doi: 10.1038/ncomms11290. Erratum in: Nat Commun. 2016 May 06;7:11633.

23.

Genome-wide analysis of DNA methylation and gene expression defines molecular characteristics of Crohn's disease-associated fibrosis.

Sadler T, Bhasin JM, Xu Y, Barnholz-Sloan J, Chen Y, Ting AH, Stylianou E.

Clin Epigenetics. 2016 Mar 12;8:30. doi: 10.1186/s13148-016-0193-6. eCollection 2016.

24.

Specific allergen immunotherapy: effect on IgE, IgG4 and chemokines in patients with allergic rhinitis.

Stylianou E, Ueland T, Borchsenius F, Michelsen AE, Øvstebø R, Mollnes TE, Skjønsberg OH, Aukrust P.

Scand J Clin Lab Invest. 2016;76(2):118-27. doi: 10.3109/00365513.2015.1110856. Epub 2016 Jan 11.

PMID:
26878875
25.

Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus.

Broesby-Olsen S, Dybedal I, Gülen T, Kristensen TK, Møller MB, Ackermann L, Sääf M, Karlsson MA, Agertoft L, Brixen K, Hermann P, Stylianou E, Mortz CG, Torfing T, Havelund T, Sander B, Bergström A, Bendix M, Garvey LH, Bjerrum OW, Valent P, Bindslev-Jensen C, Nilsson G, Vestergaard H, Hägglund H.

Acta Derm Venereol. 2016 Jun 15;96(5):602-12. doi: 10.2340/00015555-2325.

26.

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A.

Stylianou E, Griffiths KL, Poyntz HC, Harrington-Kandt R, Dicks MD, Stockdale L, Betts G, McShane H.

Vaccine. 2015 Nov 27;33(48):6800-8. doi: 10.1016/j.vaccine.2015.10.017. Epub 2015 Oct 23.

27.

The epithelial danger signal IL-1α is a potent activator of fibroblasts and reactivator of intestinal inflammation.

Scarpa M, Kessler S, Sadler T, West G, Homer C, McDonald C, de la Motte C, Fiocchi C, Stylianou E.

Am J Pathol. 2015 Jun;185(6):1624-37. doi: 10.1016/j.ajpath.2015.02.018. Epub 2015 Apr 10.

28.

RGS1 regulates myeloid cell accumulation in atherosclerosis and aortic aneurysm rupture through altered chemokine signalling.

Patel J, McNeill E, Douglas G, Hale AB, de Bono J, Lee R, Iqbal AJ, Regan-Komito D, Stylianou E, Greaves DR, Channon KM.

Nat Commun. 2015 Mar 18;6:6614. doi: 10.1038/ncomms7614.

29.

Chromosome-associated protein D3 promotes bacterial clearance in human intestinal epithelial cells by repressing expression of amino acid transporters.

Schuster AT, Homer CR, Kemp JR, Nickerson KP, Deutschman E, Kim Y, West G, Sadler T, Stylianou E, Krokowski D, Hatzoglou M, de la Motte C, Rubin BP, Fiocchi C, McDonald C, Longworth MS.

Gastroenterology. 2015 Jun;148(7):1405-1416.e3. doi: 10.1053/j.gastro.2015.02.013. Epub 2015 Feb 18.

30.

Human CD68 promoter GFP transgenic mice allow analysis of monocyte to macrophage differentiation in vivo.

Iqbal AJ, McNeill E, Kapellos TS, Regan-Komito D, Norman S, Burd S, Smart N, Machemer DE, Stylianou E, McShane H, Channon KM, Chawla A, Greaves DR.

Blood. 2014 Oct 9;124(15):e33-44. doi: 10.1182/blood-2014-04-568691. Epub 2014 Jul 16.

31.

Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG.

Pepponi I, Diogo GR, Stylianou E, van Dolleweerd CJ, Drake PM, Paul MJ, Sibley L, Ma JK, Reljic R.

Plant Biotechnol J. 2014 Sep;12(7):840-50. doi: 10.1111/pbi.12185. Epub 2014 Mar 13.

32.

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.

Poyntz HC, Stylianou E, Griffiths KL, Marsay L, Checkley AM, McShane H.

Tuberculosis (Edinb). 2014 May;94(3):226-37. doi: 10.1016/j.tube.2013.12.006. Epub 2014 Jan 2.

33.

Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.

Stylianou E, Diogo GR, Pepponi I, van Dolleweerd C, Arias MA, Locht C, Rider CC, Sibley L, Cutting SM, Loxley A, Ma JK, Reljic R.

Eur J Immunol. 2014 Feb;44(2):440-9.

34.

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice.

Griffiths KL, Stylianou E, Poyntz HC, Betts GJ, Fletcher HA, McShane H.

PLoS One. 2013 Oct 23;8(10):e78312. doi: 10.1371/journal.pone.0078312. eCollection 2013.

35.

Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A.

Matsumiya M, Stylianou E, Griffiths K, Lang Z, Meyer J, Harris SA, Rowland R, Minassian AM, Pathan AA, Fletcher H, McShane H.

PLoS One. 2013 Jul 3;8(7):e67922. doi: 10.1371/journal.pone.0067922. Print 2013.

36.

Epigenetics: the fine-tuner in inflammatory bowel disease?

Stylianou E.

Curr Opin Gastroenterol. 2013 Jul;29(4):370-7. doi: 10.1097/MOG.0b013e328360bd12. Review.

37.

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).

Marsay L, Matsumiya M, Tanner R, Poyntz H, Griffiths KL, Stylianou E, Marsh PD, Williams A, Sharpe S, Fletcher H, McShane H.

Tuberculosis (Edinb). 2013 Sep;93(5):551-7. doi: 10.1016/j.tube.2013.04.007. Epub 2013 May 31.

38.

Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery.

Pepponi I, Stylianou E, van Dolleweerd C, Diogo GR, Paul MJ, Drake PM, Ma JK, Reljic R.

PLoS One. 2013 Apr 23;8(4):e60855. doi: 10.1371/journal.pone.0060855. Print 2013.

39.

Cytokine-induced chromatin modifications of the type I collagen alpha 2 gene during intestinal endothelial-to-mesenchymal transition.

Sadler T, Scarpa M, Rieder F, West G, Stylianou E.

Inflamm Bowel Dis. 2013 Jun;19(7):1354-64. doi: 10.1097/MIB.0b013e318281f37a.

40.

Progressive dyspnea after a heavy coughing attack.

Nensa F, Stylianou E, Schroeder T.

Gastroenterology. 2013 Mar;144(3):e9-e10. doi: 10.1053/j.gastro.2012.10.026. Epub 2013 Feb 1. No abstract available.

PMID:
23380946
41.

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.

Betts G, Poyntz H, Stylianou E, Reyes-Sandoval A, Cottingham M, Hill A, McShane H.

PLoS One. 2012;7(12):e50447. doi: 10.1371/journal.pone.0050447. Epub 2012 Dec 21.

42.

Size-based clinical response evaluation is insufficient to assess clinical response of sarcomas treated with isolated limb perfusion with TNF-α and melphalan.

Grabellus F, Stylianou E, Umutlu L, Sheu SY, Lehmann N, Taeger G, Lauenstein TC.

Ann Surg Oncol. 2012 Oct;19(11):3375-85. doi: 10.1245/s10434-012-2408-1. Epub 2012 May 24.

PMID:
22622472
43.

Epigenetics: Concepts and relevance to IBD pathogenesis.

Scarpa M, Stylianou E.

Inflamm Bowel Dis. 2012 Oct;18(10):1982-96. doi: 10.1002/ibd.22934. Epub 2012 Mar 8. Review.

PMID:
22407855
44.

Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis.

Rieder F, Kessler SP, West GA, Bhilocha S, de la Motte C, Sadler TM, Gopalan B, Stylianou E, Fiocchi C.

Am J Pathol. 2011 Nov;179(5):2660-73. doi: 10.1016/j.ajpath.2011.07.042. Epub 2011 Sep 21.

45.

Molecular Pharming: future targets and aspirations.

Paul M, van Dolleweerd C, Drake PM, Reljic R, Thangaraj H, Barbi T, Stylianou E, Pepponi I, Both L, Hehle V, Madeira L, Inchakalody V, Ho S, Guerra T, Ma JK.

Hum Vaccin. 2011 Mar;7(3):375-82. Epub 2011 Mar 1. Review.

46.

Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.

Stylianou E, Pepponi I, van Dolleweerd CJ, Paul MJ, Ma JK, Reljic R.

Vaccine. 2011 Mar 9;29(12):2279-86. doi: 10.1016/j.vaccine.2011.01.030. Epub 2011 Jan 25.

PMID:
21272603
47.

Complementary PCAF-coenzyme A mutagenesis: chemoenzymatic synthesis of a novel enlarged coenzyme A analogue and evaluation of its biological activity.

Khim L, Han J, Willetts L, Brady K, Gillece P, Rached O, Thomas NR, Stylianou E.

Chembiochem. 2010 Oct 18;11(15):2100-3. doi: 10.1002/cbic.201000286. No abstract available.

PMID:
20821790
48.

Cytokine interactions that determine the outcome of Mycobacterial infection of macrophages.

Reljic R, Stylianou E, Balu S, Ma JK.

Cytokine. 2010 Jul;51(1):42-6. doi: 10.1016/j.cyto.2010.04.005.

PMID:
20434357
49.

New S-adenosyl-L-methionine analogues: synthesis and reactivity studies.

Townsend AP, Roth S, Williams HE, Stylianou E, Thomas NR.

Org Lett. 2009 Jul 16;11(14):2976-9. doi: 10.1021/ol9009859.

PMID:
19552444
50.

TNF-alpha in tuberculosis: a cytokine with a split personality.

Mootoo A, Stylianou E, Arias MA, Reljic R.

Inflamm Allergy Drug Targets. 2009 Mar;8(1):53-62. Review.

PMID:
19275693

Supplemental Content

Loading ...
Support Center